Skip to content

Supplier News

Former Genovese exec joins PearlBrite advisory board

Leonard Genovese, part of the family that ran the former Genovese Drug Stores Inc. chain, has been retained by PearlBrite Concepts Inc. to serve on its board of advisors management team. PearlBrite is a nondental, cosmetic teeth whitening company and subsidiary of Delta Entertainment Group Inc.

CeraVe introduces renewing lotion

Coria Laboratories has expanded its popular CeraVe skin care line with CeraVe SA Renewing Lotion. The Valeant Pharmaceuticals North America subsidiary said Thursday that CeraVe SA Renewing Lotion is now available at drug stores and mass retailers nationwide at a suggested retail price of $14.99.

McKesson to distribute BlueScience to pharmacies

McKesson Corp. is slated to distribute BluScience dietary supplements from ChromaDex Corp. to about 4,000 community pharmacies. ChromaDex said Wednesday that under the agreement, McKesson will distribute three BluScience supplement products to independent pharmacies: HeartBlu, EternalBlu and Blu2Go.

Nipro acquires new HQ site

Nipro Diagnostics Inc., has purchased a new corporate facility in Fort Lauderdale, Fla., to house many of its operations. The diabetes care supplier said Thursday that the building, at 2200 West Cypress Creek Rd. in Fort Lauderdale.

New chief takes over at Boehringer Ingelheim USA

Paul Fonteyne has been named U.S. country managing director and president and chief executive officer of Boehringer Ingelheim USA Corp. The Germany-based drug maker said this week that Fonteyne takes over that post from J.

CVS adopts ACI check management solution

CVS/pharmacy has implemented a check management system from ACI Worldwide Inc. that the technology provider said enables the drug chain to automate and lower the cost of check authorization. ACI said Monday that CVS/pharmacy, part of CVS Caremark Corp.

Watson releases Yaz generic

Watson Pharmaceuticals Inc. has begun shipping a Vestura, an oral contraceptive. The company said late Wednesday that the product was launched by its Watson Pharma Inc. subsidiary. Vestura (drospirenone 3 mg and ethinyl estradiol 0.